<DOC>
	<DOCNO>NCT02682849</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness PleuraFlow® Active Clearance Technology™ ( ACT ) System management blood evacuation cardiac surgery .</brief_summary>
	<brief_title>Active Clearance Technology ( ACT ) Registry</brief_title>
	<detailed_description />
	<criteria>1 . Male Female subject 18 year age old receive PleuraFlow System follow heart surgery . 2 . Patient undergoing cardiac surgery via sternotomy 1 . Robotic surgery 2 . Any access via thoracotomy 3 . Any condition deem inappropriate inclusion investigator . 4 . Intolerance implantable silicone material .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>